semaglutide compounding enforcement news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Feds warn telehealth companies about
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 39.Shen MR, Owusu-Boaitey K, Holsen LM, Suzuki J
As there is no meaningful expression of GLP-1 receptors on hepatocytes, the major effect of GLP-1 agonists on MASH is likely to be indirect and may be related to a reduction in calorie intake, body weight and insulin resistance, all of which would lead to reduced liver lipid accumulation and hepatic inflammation 7,8
During your regular check-ins at our practice, our experienced healthcare professionals conduct detailed assessments tailored to your unique needs
Their availability in oral and injectable formulations also enhances patient adherence
If you still need help managing your blood sugar levels your dose will increase to 14mg once a day
Retatrutide is in phase 3 clinical trials
